Chemotherapy for pancreatic cancer: the rise of multidrug regimens

David Malka; Ivan Borbath; Thierry Conroy

doi:10.1016/s2468-1253(18)30235-8

Chemotherapy for pancreatic cancer: the rise of multidrug regimens

David Malka, Ivan Borbath, Thierry Conroy

Research output: Contribution to journal › Comment/debate

2 Scopus citations

Original language	English
Pages (from-to)	659-660
Number of pages	2
Journal	The Lancet Gastroenterology and Hepatology
Volume	3
Issue number	10
DOIs	https://doi.org/10.1016/s2468-1253(18)30235-8
State	Published - Oct 2018
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/s2468-1253(18)30235-8

Cite this

@article{5d1e38c77baa4ae99ec6730fd1fd9d45,

title = "Chemotherapy for pancreatic cancer: the rise of multidrug regimens",

author = "David Malka and Ivan Borbath and Thierry Conroy",

year = "2018",

month = oct,

doi = "10.1016/s2468-1253(18)30235-8",

language = "אנגלית",

volume = "3",

pages = "659--660",

journal = "The Lancet Gastroenterology and Hepatology",

issn = "2468-1253",

publisher = "Elsevier Ltd.",

number = "10",

}

TY - JOUR

T1 - Chemotherapy for pancreatic cancer

T2 - the rise of multidrug regimens

AU - Malka, David

AU - Borbath, Ivan

AU - Conroy, Thierry

PY - 2018/10

Y1 - 2018/10

UR - http://www.scopus.com/inward/record.url?scp=85052732651&partnerID=8YFLogxK

U2 - 10.1016/s2468-1253(18)30235-8

DO - 10.1016/s2468-1253(18)30235-8

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.comment???

C2 - 30215353

AN - SCOPUS:85052732651

SN - 2468-1253

VL - 3

SP - 659

EP - 660

JO - The Lancet Gastroenterology and Hepatology

JF - The Lancet Gastroenterology and Hepatology

IS - 10

ER -

Chemotherapy for pancreatic cancer: the rise of multidrug regimens

UN SDGs

Access to Document

Other files and links

Cite this